Collagen, Type I, alpha 1 (COL1A1) Peptide
COL1A1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all COL1A1 products
- COL1A1 (Collagen, Type I, alpha 1 (COL1A1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GLGRQVYDPK YCAAPTEPVI HNGSQGTGTN GSEISDSDYQ AEYPDEYHGE
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of COL1 A1 antibody,
Alternative Names: COL1A1 control peptide, COL1A1 antibody Blocking Peptide, Anti-COL1A1 Blocking Peptide, collagen, type I, alpha 1 Blocking Peptide, OI4 Blocking Peptide, COL1A1, COLA-1, COLA 1, COLA-1 Blocking Peptide, COLA 1 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- COL1A1 (Collagen, Type I, alpha 1 (COL1A1))
- Background
- This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor.
- Molecular Weight
- 36 kDa
-
You are here:
